Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.59 |
| ▸ | RAB9A | P51151 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 2/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10047628 | 0.93 | LTA4H (0.54) | MEN1KMT2ARAB9AMAPK1MAPT | |
| SCHEMBL15679887 | 0.93 | ABL1 (0.59) | MEN1KMT2ARAB9AMAPK1MAPT | |
| SCHEMBL9301 | 0.92 | — | — | |
| SCHEMBL3862399 | 0.91 | ALDH1A1 (0.65) | MEN1KMT2ARAB9AMAPK1MAPT | |
| SCHEMBL10605468 | 0.89 | CA1 (0.65) | MEN1KMT2ARAB9AMAPK1MAPT | |
| Bromomethane SCHEMBL9702151 | 0.89 | CA1 (0.65) | MEN1KMT2ARAB9AMAPK1MAPT | |
| Phosphine SCHEMBL9754815 | 0.89 | CA1 (0.65) | MEN1KMT2ARAB9AMAPK1MAPT | |
| SCHEMBL5466009 | 0.89 | CA1 (0.65) | MEN1KMT2ARAB9AMAPK1MAPT | |
| Magnesium SCHEMBL31191739 | 0.89 | CA1 (0.65) | MEN1KMT2ARAB9AMAPK1MAPT | |
| SCHEMBL109479 | 0.89 | CA1 (0.65) | MEN1KMT2ARAB9AMAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025066980-A1 | PHOSPHORUS-CONTAINING TRIANHYDRIDE MONOMER AND PREPARATION METHOD THEREFOR, AND POLYIMIDE MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | 比亚迪股份有限公司 | 2025-04-03 | — | — | WO | claimed |
| CN-118221734-A | Phosphoric dianhydride monomer and preparation method thereof, polyimide material and preparation method and application thereof | 比亚迪股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| US-20260115296-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES | UNIV YALE (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2025108154-A1 | POLYCYCLIC COMPOUND AND USE THEREOF | HUAHUI HEALTH LTD. (CN) | 2025-05-30 | — | — | WO | disclosed |
| CN-119781244-A | Photosensitive composition for color filter, image display device, and solid-state imaging element | 爱天思株式会社 | 2025-04-08 | — | — | CN | disclosed |
| CN-119751504-A | Acid compound, polyimide covalent organic framework, and preparation methods and applications thereof | 比亚迪股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| WO-2025066980-A1 | PHOSPHORUS-CONTAINING TRIANHYDRIDE MONOMER AND PREPARATION METHOD THEREFOR, AND POLYIMIDE MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | 比亚迪股份有限公司 | 2025-04-03 | — | — | WO | disclosed |
| CN-119504463-A | Hole transport material, synthesis method, perovskite solar cell and preparation method | 晶澳（扬州）太阳能科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| US-12115154-B2 | Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) | SRX CARDIO, LLC (US) | 2024-10-15 | — | — | US | disclosed |
| CN-118324596-A | Synthesis method of biaryl compound | 新疆大学 | 2024-07-12 | — | — | CN | disclosed |
| CN-118221734-A | Phosphoric dianhydride monomer and preparation method thereof, polyimide material and preparation method and application thereof | 比亚迪股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| WO-1998003166-A1 | THIOL SULFONAMIDE METALLOPROTEASE INHIBITORS | MONSANTO COMPANY (US) | 1998-01-29 | — | — | WO | disclosed |
| EP-0343606-B1 | An engineering plastic composition and an article made of the same | SEIKISUI CHEMICAL CO LTD (JP) | 1995-01-18 | — | — | EP | disclosed |
| EP-0438754-B1 | Optically active compound, intermediate therefor, process for producing the intermediate, and liquid-crystal composition | DAINIPPON INK & CHEMICALS (JP) | 1994-08-17 | — | — | EP | disclosed |
| EP-0390945-B1 | Process for preparing 4,4'''-dihydroxyquater-phenyl or derivatives thereof | SANKO KAIHATSU KAGAKU KENK (JP) | 1993-11-18 | — | — | EP | disclosed |
| US-5064564-A | Ferroelectric liquid crystal display | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-11-12 | — | — | US | disclosed |
| EP-0438754-A1 | Optically active compound, intermediate therefor, process for producing the intermediate, and liquid-crystal composition | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-07-31 | — | — | EP | disclosed |
| US-5011879-A | With adjuvants of p-quaterphenyl or its hydroxy, alkoxy or alkyl ester derivatives; melt viscosity, heat resistance, molding materials | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-04-30 | — | — | US | disclosed |
| EP-0390945-A1 | Process for preparing 4,4'''-dihydroxyquater-phenyl or derivatives thereof | Sanko Kaihatsu Kagaku Kenkyusho (JP) | 1990-10-10 | — | — | EP | disclosed |
| EP-0343606-A1 | An engineering plastic composition and an article made of the same | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12115154-B2 | Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) | PCSK9, PCSK6, PCSK7 | MEN1 1661/4885KMT2A 3880/4885RAB9A 753/4885 |
| US-20260115296-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES | CRBN, VHL, ADRM1 | MEN1 3186/4885KMT2A 2541/4885RAB9A 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.